Benutzerspezifische Werkzeuge

Selection of relevant previous publications

Here is a list of KFO252-relevant publications (before 2011) from members of Project 9:
  1. Ludwig B, Zimerman B, Steffen A, Yavriants K, Azarov D, Reichel A, Vardi P, German T, Shabtay N, Rotem A, Evron Y, Neufeld T, Mimon S, Ludwig S, Brendel MD, Bornstein SR, Barkai U. A novel device for islet transplantation providing immune protection and oxygen supply. Horm Metab Res. 2010;42:918-22.
  2. Ludwig B, Ziegler CG, Schally AV, Richter C, Steffen A, Jabs N, Funk RH, Brendel MD, Block NL, Ehrhart-Bornstein M, Bornstein SR. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci U S A. 2010;107:12623-8.
  3. Cardoso CC, Bornstein SR, Hornsby PJ. Optimizing orthotopic cell transplantation in the mouse adrenal gland. Cell Transplant. 2010;19:565-72.
  4. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009;360:2328-39.
  5. Reimann M, Bonifacio E, Solimena M, Schwarz PE, Ludwig B, Hanefeld M, Bornstein SR. An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Ther. 2009;121:317-31.
  6. Muller G, Morawietz H. Nitric oxide, NAD(P)H oxidase and atherosclerosis. Antioxid Redox Signal.2009;11:1711-31.
  7. Armann B, Hanson MS, Hatch E, Steffen A, Fernandez LA. Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant. 2007;7:38-47.
  8. Rueckschloss U, Galle J, Holtz J, Zerkowski H-R, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of HMG-CoA reductase inhibitor therapy. Circulation. 2001;104:1767-72.